Skip to content
Trial Eligibility
Menu

CYP2C19 Variants and Limonene Metabolism

NCT05078723

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The investigators will examine whether a non-invasive screening tool for CYP2C19 genetic variants can be developed by measuring limonene metabolism.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • CYP2C19 Genetic Variants

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 45 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Stanford University
Last updated on ClinicalTrials.gov
December 16, 2024

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Stanford School of Medicine · Stanford, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.